Altimmune, Inc. (ALT) vs Contineum Therapeutics, Inc. (CTNM)
A side-by-side comparison of Altimmune, Inc. and Contineum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALT
Altimmune, Inc.
$2.68HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
CTNM
Contineum Therapeutics, Inc.
$12.61HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — ALT vs CTNM
growth of $100 · dividends reinvested · last 2yALT -70.6% (-45.8%/yr)CTNM -17.4% (-9.1%/yr)CTNM compounded faster over this window
ALT CTNM
ALT vs CTNM: by the numbers
- •ALT is the larger company ($520M vs $474M market cap).
- •Both run net losses; CTNM's is the smaller (0.00% vs -296000.00% net margin).
Metrics side by side
Valuation
| Metric | ALT | CTNM |
|---|---|---|
| P/S ratio | 16781.22 | N/A |
| P/B ratio | 1.10 | 1.98 |
Profitability
| Metric | ALT | CTNM |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -230460.98% | 0.00% |
| Net margin | -296000.00% | 0.00% |
| ROE | -19.35% | -24.02% |
| ROIC | -19.47% | -27.22% |
Growth (annualized)
| Metric | ALT | CTNM |
|---|---|---|
| Revenue CAGR (5Y) | -65.38% | N/A |
| Total return CAGR (5Y) | -25.30% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.